Eltrombopag

Chemical compound

Last price

—

Floor price

—

7-day median

—

30-day sales

30-day range

—

In circulation

Price history

Show table

Date	median	Low	High	sales

Sales history

Last sale: —
30-day average: —
30-day low: —
30-day high: —
Sales 7d: 0
Sales 30d: 0

No sales yet.

Anonymous sales: no buyer or seller shown. Figures count player-to-player sales only.

From Wikipedia

Eltrombopag, sold under the brand name Promacta among others, is a medication used to treat thrombocytopenia (abnormally low platelet counts) and severe aplastic anemia. It is a thrombopoietin receptor agonist. It is taken by mouth. Eltrombopag was discovered as a result of research collaboration between GlaxoSmithKline and Ligand Pharmaceuticals and is transferred to Novartis Pharmaceuticals. Eltrombopag was approved for medical use in the US in November 2008, and authorized in the European Union in March 2010.

Text: Wikipédia, CC BY-SA 4.0. · Image: Fvasconcellos 02:06, 29 November 2007 (UTC) (Public domain) ·

Related cards

Methyldopa

Chemical compound

Nº Q412621 ★★

Beta blocker

Class of medications that are particularly used to manage cardiac arrhythmias, and to protect the heart from a second heart attack after a first heart attack

Nº Q816759 ★★★★